Martin Brenner
Chief Executive Officer and Chief Scientific Officer, Director · iBio, Inc.
- 2025
- Mar 23, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Martin Brenner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Felipe Duran - $50K in IBIO purchases and sales in the last 12 months
- Marc Banjak - $23K in IBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Martin Brenner?
Martin Brenner is a corporate insider, tracked as Chief Executive Officer and Chief Scientific Officer, Director of iBio, Inc. (IBIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Martin Brenner last file a Form 4?
The most recent primary Form 4 on record is dated 23 March 2026, one of 3 filings going back to 2025.
Has Martin Brenner been buying or selling stock?
Recorded transactions: 1 open-market purchase ($25K) and 0 open-market sales across all tracked filings.
